Cytokinetics Inc (CYTK)
59.53
-0.39
(-0.65%)
USD |
NASDAQ |
May 17, 16:00
59.57
+0.04
(+0.07%)
After-Hours: 20:00
Cytokinetics Stock Buybacks (Quarterly): -93.64M for March 31, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -93.64M |
| December 31, 2023 | -162.92M |
| September 30, 2023 | -1.312M |
| June 30, 2023 | |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | -15.14M |
| September 30, 2021 | -296.90M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 0.00 |
| September 30, 2020 | -225.11M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 0.00 |
| September 30, 2019 | -11.40M |
| June 30, 2019 | -19.70M |
| March 31, 2019 | -5.117M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.008M |
| June 30, 2017 | -94.88M |
| March 31, 2017 | -24.92M |
| December 31, 2016 | |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | -9.102M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | -39.87M |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.033M |
| June 30, 2013 | -7.483M |
| March 31, 2013 | 0.00 |
| December 31, 2012 | -0.36M |
| September 30, 2012 | 0.409M |
| June 30, 2012 | -43.73M |
| March 31, 2012 | 0.00 |
| December 31, 2011 | -0.055M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-296.90M
Minimum
Sep 2021
--
Maximum
Dec 2019
-63.55M
Average
-11.40M
Median
Sep 2019
Stock Buybacks (Quarterly) Benchmarks
| Amgen Inc | -- |
| Johnson & Johnson | 1.475B |
| Viking Therapeutics Inc | -597.12M |
| Eli Lilly and Co | 0.00 |
| Madrigal Pharmaceuticals Inc | -311.56M |